CIK: 0001710065 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 10, 2021
Total Value ($000): $173,431 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 1,064,962 | $67,306 | 38.8% | $42.30 | +22.0% | COM | 03753U106 |
| AVIR | ATEA PHARMACEUTICALS INC | 1,745,331 | $37,490 | 21.6% | $32.23 | -6.8% | COM | 04683R106 |
| KYMR | KYMERA THERAPEUTICS INC | 639,059 | $30,994 | 17.9% | $48.78 | -11.0% | COM | 501575104 |
| SEER | SEER INC | 816,375 | $26,761 | 15.4% | $63.62 | -38.0% | COM CL A | 81578P106 |
| — | SUTRO BIOPHARMA INC | 175,000 | $3,253 | 1.9% | $21.71 | — | COM | 869367102 |
| — | RAPT THERAPEUTICS INC | 99,503 | $3,163 | 1.8% | $19.75 | — | COM | 75382E109 |
| — | MOLECULAR TEMPLATES INC | 204,809 | $1,602 | 0.9% | $9.39 | — | COM | 608550109 |
| — | CLEARSIDE BIOMEDICAL INC | 293,555 | $1,430 | 0.8% | $2.74 | — | COM | 185063104 |
| — | KEZAR LIFE SCIENCES INC | 128,916 | $700 | 0.4% | $5.22 | — | COM | 49372L100 |
| — | AILERON THERAPEUTICS INC | 517,558 | $647 | 0.4% | $1.04 | — | COM | 00887A105 |
| — | BELLICUM PHARMACEUTICALS INC | 25,651 | $85 | 0.0% | $3.55 | — | COM NEW | 079481404 |